Oncotarget
Journal
Overview
publication venue for
-
Genetic alterations in thyroid cancer mediating both resistance to BRAF inhibition and anaplastic transformation..
15.
2024
-
Targeting GITR in cancer immunotherapy - there is no perfect knowledge..
14.
2023
-
Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers..
13.
2022
-
The role of immune surveillance in malignant transformation of benign salivary gland tumors..
12.
2021
-
A 3D biofabricated cutaneous squamous cell carcinoma tissue model with multi-channel confocal microscopy imaging biomarkers to quantify antitumor effects of chemotherapeutics in tissue..
11.
2020
-
Reassessing the role of high dose cytarabine and mitoxantrone in relapsed/refractory acute myeloid leukemia..
11.
2020
-
Efficacy of osimertinib against EGFRvIII+ glioblastoma..
11.
2020
-
Exercise reduces immune suppression and breast cancer progression in a preclinical model..
11.
2020
-
Extramammary Paget disease shows differential expression of B7 family members B7-H3, B7-H4, PD-L1, PD-L2 and cancer/testis antigens NY-ESO-1 and MAGE-A..
10.
2019
-
Contemplations on MDMX (MDM4) driving triple negative breast cancer circulating tumor cells and metastasis..
10.
2019
-
Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort..
10.
2019
-
ETHE1 overexpression promotes SIRT1 and PGC1α mediated aerobic glycolysis, oxidative phosphorylation, mitochondrial biogenesis and colorectal cancer..
10.
2019
-
Immunomodulatory and immunotherapeutic implications of tobacco smoking in squamous cell carcinomas and normal airway epithelium..
10.
2019
-
Thyroid hormones induce doxorubicin chemosensitivity through enzymes involved in chemotherapy metabolism in lymphoma T cells..
10.
2019
-
Septin-2 is overexpressed in epithelial ovarian cancer and mediates proliferation via regulation of cellular metabolic proteins..
10.
2019
-
Preoperative MRI-radiomics features improve prediction of survival in glioblastoma patients over MGMT methylation status alone..
10.
2019
-
Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancer..
9.
2018
-
Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance..
9.
2018
-
Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigation..
9.
2018
-
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications..
9.
2018
-
Lysis-independent potentiation of immune checkpoint blockade by oncolytic virus..
9.
2018
-
Activity of roniciclib in medullary thyroid cancer..
9.
2018
-
Safety and pharmacokinetics of DS-6051b in Japanese patients with non-small cell lung cancer harboring ROS1 fusions: a phase I study..
9.
2018
-
Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies..
9.
2018
-
Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells..
9.
2018
-
Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively..
9.
2018
-
A pilot study of durvalumab and tremelimumab and immunogenomic dynamics in metastatic breast cancer..
9.
2018
-
Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer..
9.
2018
-
Analysis of hematological parameters as prognostic markers for toxicity and survival of 223Radium treatment..
9.
2018
-
Pre-diagnostic biomarkers of metabolic dysregulation and cancer mortality..
9.
2018
-
Mandatory role of HMGA1 in human airway epithelial normal differentiation and post-injury regeneration..
9.
2018
-
Systematic identification of functionally relevant risk alleles to stratify aggressive versus indolent prostate cancer..
9.
2018
-
Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia..
9.
2018
-
The ERβ4 variant induces transformation of the normal breast mammary epithelial cell line MCF-10A; the ERβ variants ERβ2 and ERβ5 increase aggressiveness of TNBC by regulation of hypoxic signaling..
9.
2018
-
Potential for subsets of wt-NPM1 primary AML blasts to respond to retinoic acid treatment..
9.
2017
-
A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatment..
8.
2017
-
Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age: data from the malmö preventive project..
9.
2017
-
Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT..
8.
2017
-
Hypoxia-inducible factor-1α regulates microglial functions affecting neuronal survival in the acute phase of ischemic stroke in mice..
8.
2017
-
Detection of HPV related oropharyngeal cancer in oral rinse specimens..
8.
2017
-
Pharmacodynamic and pharmacokinetic neoadjuvant study of hedgehog pathway inhibitor Sonidegib (LDE-225) in men with high-risk localized prostate cancer undergoing prostatectomy..
8.
2017
-
Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression..
8.
2017
-
Dissecting the mechanisms involved in anti-human T-lymphocyte immunoglobulin (ATG)-induced tolerance in the setting of allogeneic stem cell transplantation - potential implications for graft versus host disease..
8.
2017
-
LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway..
8.
2017
-
Somatic mutations in CDH1 and CTNNB1 in primary carcinomas at 13 anatomic sites..
8.
2017
-
Differential response to exercise in claudin-low breast cancer..
8.
2017
-
Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation..
8.
2017
-
Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1..
8.
2017
-
Activating mutation of PDGFRB gene in a rare cardiac undifferentiated intimal sarcoma of the left atrium: a case report..
8.
2017
-
High-resolution microbiome profiling uncovers Fusobacterium nucleatum, Lactobacillus gasseri/johnsonii, and Lactobacillus vaginalis associated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation..
8.
2017
-
MYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-GD2 immunotherapy..
8.
2017
-
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis..
8.
2017
-
Targeting of PHOX2B expression allows the identification of drugs effective in counteracting neuroblastoma cell growth..
8.
2017
-
Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells..
8.
2017
-
In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME)..
8.
2017
-
Aurora kinase B dependent phosphorylation of 53BP1 is required for resolving merotelic kinetochore-microtubule attachment errors during mitosis..
8.
2017
-
Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic mice..
8.
2017
-
Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway..
8.
2017
-
Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor-naïve patients with non-small cell lung cancer harboring EGFR mutations..
8.
2017
-
Effects of roniciclib in preclinical models of anaplastic thyroid cancer..
8.
2017
-
Recombinant TAT-BMI-1 fusion protein induces ex vivo expansion of human umbilical cord blood-derived hematopoietic stem cells..
8.
2017
-
Local recurrences at the anastomotic area are clonally related to the primary tumor in sporadic colorectal carcinoma..
8.
2017
-
Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models..
8.
2017
-
Dectin-1 signaling inhibits osteoclastogenesis via IL-33-induced inhibition of NFATc1..
8.
2017
-
Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer..
8.
2017
-
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition..
8.
2017
-
Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab..
8.
2017
-
AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling..
8.
2017
-
Transcriptional regulation of mixed lineage kinase 3 by estrogen and its implication in ER-positive breast cancer pathogenesis..
8.
2017
-
Inhibition of colorectal cancer genomic copy number alterations and chromosomal fragile site tumor suppressor FHIT and WWOX deletions by DNA mismatch repair..
8.
2017
-
Genetic defects of the IRF1-mediated major histocompatibility complex class I antigen presentation pathway occur prevalently in the JAK2 gene in non-small cell lung cancer..
8.
2017
-
PPARs as determinants of the estrogen receptor lineage: use of synthetic lethality for the treatment of estrogen receptor-negative breast cancer..
8.
2017
-
Calcium-regulatory proteins as modulators of chemotherapy in human neuroblastoma..
8.
2017
-
Inhibiting DNA-PKcs in a non-homologous end-joining pathway in response to DNA double-strand breaks..
8.
2017
-
PI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases..
8.
2017
-
Unique synergistic formulation of curcumin, epicatechin gallate and resveratrol, tricurin, suppresses HPV E6, eliminates HPV+ cancer cells, and inhibits tumor progression..
8.
2017
-
MicroRNA-203 predicts human survival after resection of colorectal liver metastasis..
8.
2017
-
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation..
8.
2017
-
Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma..
8.
2017
-
Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells..
8.
2017
-
The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer..
8.
2017
-
Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer..
7.
2016
-
OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations..
7.
2016
-
Quantification of tumor-derived cell free DNA(cfDNA) by digital PCR (DigPCR) in cerebrospinal fluid of patients with BRAFV600 mutated malignancies..
7.
2016
-
Acid ceramidase is upregulated in AML and represents a novel therapeutic target..
7.
2016
-
Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma..
7.
2016
-
Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes..
7.
2016
-
T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts..
7.
2016
-
Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening..
7.
2016
-
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21..
7.
2016
-
Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA..
7.
2016
-
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia..
7.
2016
-
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells..
7.
2016
-
IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens..
7.
2016
-
Scaffold attachment factor A (SAF-A) and Ku temporally regulate repair of radiation-induced clustered genome lesions..
7.
2016
-
Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy..
7.
2016
-
Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma..
7.
2016
-
YKT6 expression, exosome release, and survival in non-small cell lung cancer..
7.
2016
-
Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells..
7.
2016
-
STAT5 induces miR-21 expression in cutaneous T cell lymphoma..
7.
2016
-
Targeting cancer stem cells with p53 modulators..
7.
2016
-
The metabolic/pH sensor soluble adenylyl cyclase is a tumor suppressor protein..
7.
2016
-
BO-1055, a novel DNA cross-linking agent with remarkable low myelotoxicity shows potent activity in sarcoma models..
7.
2016
-
Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy..
7.
2016
-
Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer..
7.
2016
-
Phospholipid scramblase 1 as a critical node at the crossroad between autophagy and apoptosis in mantle cell lymphoma..
7.
2016
-
Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma..
7.
2016
-
Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance..
7.
2016
-
Altered expression pattern of circular RNAs in primary and metastatic sites of epithelial ovarian carcinoma..
7.
2016
-
Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma..
7.
2016
-
Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma..
7.
2016
-
CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma..
7.
2016
-
A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells..
7.
2016
-
Analysis of tumor template from multiple compartments in a blood sample provides complementary access to peripheral tumor biomarkers..
7.
2016
-
MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer..
7.
2016
-
MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor..
7.
2016
-
Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repair..
7.
2016
-
Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis..
7.
2016
-
Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival..
7.
2016
-
Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression..
7.
2016
-
VE-cadherin cleavage by ovarian cancer microparticles induces β-catenin phosphorylation in endothelial cells..
7.
2016
-
Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib..
7.
2016
-
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin..
7.
2016
-
Monoamine oxidase B levels are highly expressed in human gliomas and are correlated with the expression of HiF-1α and with transcription factors Sp1 and Sp3..
7.
2016
-
NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms..
7.
2016
-
Oncogenic KRAS activates an embryonic stem cell-like program in human colon cancer initiation..
7.
2016
-
Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma..
7.
2016
-
CD4⁺ T cells play a crucial role for lenalidomide in vivo anti-tumor activity in murine multiple myeloma..
6.
2015
-
MiR137 is an androgen regulated repressor of an extended network of transcriptional coregulators..
6.
2015
-
Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome..
6.
2015
-
Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway..
6.
2015
-
Visualizing the antivascular effect of bortezomib on the hypoxic tumor microenvironment..
6.
2015
-
Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways..
6.
2015
-
APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls..
6.
2015
-
Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration..
6.
2015
-
Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers deposition..
6.
2015
-
Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma..
6.
2015
-
Gene expression profiling signatures for the diagnosis and prevention of oral cavity carcinogenesis-genome-wide analysis using RNA-seq technology..
6.
2015
-
Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma..
6.
2015
-
ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma..
6.
2015
-
Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma..
6.
2015
-
Predictors of early treatment discontinuation in patients enrolled on Phase I oncology trials..
6.
2015
-
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer..
6.
2015
-
Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma--is it necessary?.
6.
2015
-
Pit-1 inhibits BRCA1 and sensitizes human breast tumors to cisplatin and vitamin D treatment..
6.
2015
-
CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities..
6.
2015
-
High mesothelin expression in advanced lung adenocarcinoma is associated with KRAS mutations and a poor prognosis..
6.
2015
-
Anti-β₂-microglobulin monoclonal antibodies overcome bortezomib resistance in multiple myeloma by inhibiting autophagy..
6.
2015
-
Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors..
6.
2015
-
Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma..
6.
2015
-
MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition..
6.
2015
-
Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries..
6.
2015
-
Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma..
6.
2015
-
Initiation of esophageal squamous cell carcinoma (ESCC) in a murine 4-nitroquinoline-1-oxide and alcohol carcinogenesis model..
6.
2015
-
HDAC1,2 inhibition impairs EZH2- and BBAP-mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma..
6.
2015
-
The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients..
6.
2015
-
Evaluation of azacitidine and entinostat as sensitization agents to cytotoxic chemotherapy in preclinical models of non-small cell lung cancer..
6.
2015
-
Metformin and erlotinib synergize to inhibit basal breast cancer..
5.
2014
-
Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas..
5.
2014
-
Selective targeting of KRAS-mutant cells by miR-126 through repression of multiple genes essential for the survival of KRAS-mutant cells..
5.
2014
-
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells..
5.
2014
-
MicroRNA profiling of novel African American and Caucasian Prostate Cancer cell lines reveals a reciprocal regulatory relationship of miR-152 and DNA methyltranferase 1..
5.
2014
-
Nuclear retention of Fbw7 by specific inhibitors of nuclear export leads to Notch1 degradation in pancreatic cancer..
5.
2014
-
Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers..
5.
2014
-
Identification of anaplastic lymphoma kinase as a potential therapeutic target in Basal Cell Carcinoma..
4.
2013
-
Alterations of immune response of Non-Small Cell Lung Cancer with Azacytidine..
4.
2013
-
Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine..
4.
2013
-
Small-Molecule targeting of translation initiation for cancer therapy..
4.
2013
-
Effects of CT-Xp gene knock down in melanoma cell lines..
4.
2013
-
Superior efficacy of co-treatment with dual PI3K/mTOR inhibitor NVP-BEZ235 and pan-histone deacetylase inhibitor against human pancreatic cancer..
3.
2012
-
Sox9 is required for prostate development and prostate cancer initiation..
3.
2012
-
Pooled shRNA screen for sensitizers to inhibition of the mitotic regulator polo-like kinase (PLK1)..
2.
2011
-
Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders..
2.
2011
-
The class I HDAC inhibitor MGCD0103 induces cell cycle arrest and apoptosis in colon cancer initiating cells by upregulating Dickkopf-1 and non-canonical Wnt signaling..
1.
2010
-
A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers..
1.
2010
-
CD277 is a negative co-stimulatory molecule universally expressed by ovarian cancer microenvironmental cells..
1.
2010
-
It's a numbers game-density-dependent MMP activity mediates cancer cell migration..
9.
2018
-
Innovating and expanding weight loss strategies for breast cancer survivors..
12.
2021
-
MACROD2 deletions cause impaired PARP1 activity and chromosome instability in colorectal cancer..
9.
2018
-
Disabling an oncogenic transcription factor by targeting of control kinases..
9.
2018
-
Avelumab demonstrates promise in advanced NSCLC..
8.
2017
-
Multiple arterial grafting and ostriches: let's all take heart!.
8.
2017
-
RBP-J and ITAM crosstalk..
6.
2015
-
Fatty acid synthesis and NLRP3-inflammasome..
6.
2015
-
Microbial control of intestinal innate immunity..
6.
2015
-
BRAF-mutant hematopoietic malignancies..
5.
2014
-
Asymmetric division: a marker for cancer stem cells in early stage tumors?.
4.
2013
-
Reaching un-drugable intracellular targets with the long arm of antibodies..
4.
2013
-
Targeting lymphomas through MALT1 inhibition..
3.
2012
-
The heterogeneous landscape of ALK negative ALCL.
2017
-
The role of long non-coding RNAs in nasopharyngeal carcinoma: As systemic review.
2017
-
Discovery and clinical introduction of first-in-class imipridone ONC201.
2016
-
Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials.
2017
-
Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?
2017
-
Oncologic and obstetrical outcomes with fertility-sparing treatment of cervical cancer: a systematic review and meta-analysis.
2017
-
Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia.
2017
-
Developmental therapeutics for inflammatory breast cancer: Biology and translational directions.
2017
-
Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials.
2017
-
Classification of current anticancer immunotherapies.
2014
Identity
ISO Abbreviation
Linking ISSN
Electronic International Standard Serial Number (EISSN)